Search for: "DANIEL A OUELLETTE" Results 41 - 60 of 65
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2009, 4:26 am
Danielle S. 25, of Revere, (hereinafter, "Defendant 2") was also arrested at the scene, at 8:59 p.m. [read post]
18 Dec 2012, 12:33 pm by Luke Rioux
Ouellette 2012 ME 11Self defense applies to reckless conduct. [read post]
1 Nov 2021, 11:53 am by Jason Rantanen
Thomas, Cases and Materials on Patent Law (West Academic 2019) Daniel H. [read post]
2 Feb 2010, 3:16 am by Jim Walker
George, Antigua Barbuda led by Corporal Marlon Proctor have arrested and charged Tishara Daniel of Sweets Village, Antigua with the murder of our daughter. [read post]
11 Mar 2014, 7:53 am by Guest Blogger
Lisa Larrimore Ouellette is a fellow at the Information Society Project. [read post]
11 Apr 2019, 5:32 am by Eric Goldman
Instead, after Harry’s ousting, Harry’s brother Daniel allegedly raided the account and bargained to swap information from Harry’s account with Hall for mutual benefit. [read post]
24 Jun 2016, 9:05 am by Amy Howe
At Legal Aggregate, Lisa Ouellette analyzes the Court’s recent decision in Cuozzo Speed Technologies v. [read post]
14 Mar 2014, 12:46 pm by Guest Blogger
  As Lisa Larrimore Ouellette observes in her blog post for this conference, and co-authored paper with Daniel Hemel, delayed and speculative rewards under an ex post incentive regime can deter creative investment. [read post]
5 Mar 2020, 5:15 am by Léon Dijkman
Daniel Hemel and Lisa Larrimore Ouellette suggested that the government award a "large cash prize for any firm that develops a successful coronavirus vaccine". [read post]
20 Jun 2016, 3:12 am by Amy Howe
” In another post at Legal Aggregate, Lisa Ouellette weighs in on the Court’s recent ruling in Halo Electronics v. [read post]
12 May 2020, 7:49 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
31 May 2017, 4:59 am by Edith Roberts
” At Written Description, Daniel Hemel and Lisa Ouellette observe that the opinion “opens the door for creative contract lawyers to draft licensing agreements that severely restrict resale of patented products” and that its impact “will depend on how courts view the newfangled licensing agreements that are almost certain to follow. [read post]
6 Jan 2015, 6:46 pm by Bridget Crawford
Louis University Colleen Chien colleen_chien Santa Clara Luis Chiesa proflchiesa Buffalo Andrew Chin chinunc UNC Kenneth Ching kennyching Regent Cyra Akila Choudhury cyrachoudhury Florida International Allison Christians taxpolblog McGill Chester Chuang ChesterChuang Golden Gate Danielle Citron daniellecitron Maryland Robert Clinton robertclinton Arizona  State David S. [read post]
6 Feb 2015, 6:00 am by Bridget Crawford
  You can subscribe to the list at Professor Ouellette's Twitter page here. [read post]
22 Mar 2017, 4:42 am by Edith Roberts
” In a Wall Street Journal op-ed, Daniel Hamel and Lisa Larrimore Ouellette maintain that the case is essentially “about price discrimination, the practice of charging higher prices to customers who likely can pay more and offering discounts to those who cannot,” and they urge the justices to “consider what their decision might mean for consumers beyond the U.S. [read post]
6 Oct 2014, 5:36 am by Amy Howe
  At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
21 Jan 2015, 2:46 am by Amy Howe
  Commentary comes from Lisa Larrimore Ouellette at Written Description. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
As Daniel Hemel and Lisa Ouellette have written, “[g]overnments can offer strong incentives to drug makers while ensuring affordability by committing to patent buyouts for effective treatments. [read post]
9 Mar 2018, 12:54 pm by Camilla Alexandra Hrdy
To give one example, in their recent article, Bayh-Dole Without Borders, Lisa Larrimore Ouellette and Daniel Hemel observe that an under-appreciated feature of making federal funding for research work as an economic policy is ensuring that U.S. companies are able to protect the results of that federally-funded research abroad. [read post]